Menu
Back to Journals » Clinical and Experimental Gastroenterology » Volume 11
Original Research
A study of the circulating fibroblast growth factor 21 as a novel noninvasive biomarker of hepatic injury in genotype-4 chronic hepatitis C: Egyptian patients and their response to direct-acting antiviral agents
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 6,677 | Dovepress* | 6,393+ | 787 | 7,180 | |
| PubMed Central* | 284 | 89 | 373 | ||
| Totals | 6,677 | 876 | 7,553 | ||
| *Since 24 October 2018 | |||||
View citations on PubMed Central and Google Scholar